Suppr超能文献

[垂体甲状腺模拟抗受体抗体经胎盘转移导致的暂时性新生儿甲状腺功能减退症。病例报告及估计发病率]

[Transitory neonatal hypothyroidism caused by transplacental transfer of anti-receptor antibodies of hypophyseal thyroid simulation. Case report and estimated incidence].

作者信息

Pasquier S, Torresani T, Werder E, Gnehm H E

机构信息

Kinderklinik Aarau, Zürich.

出版信息

Schweiz Med Wochenschr. 1997 Nov 1;127(44):1824-8.

PMID:9446201
Abstract

Transient neonatal hypothyroidism induced by transplacental transfer of thyrotropin receptor-blocking antibodies is rare, but should be diagnosed early because its course, treatment, and prognosis are different from the other forms of congenital hypothyroidism. Transient neonatal hypothyroidism should be suspected in infants with a history of maternal autoimmune thyroid disease. We describe two siblings whose mother has been treated for idiopathic primary nongoitrous hypothyroidism since adolescence. High levels of thyrotropin receptor-blocking antibodies were first detected in maternal serum at the time of the first child's birth. At the time of the second child's birth antithyroid peroxidase antibodies were found in addition to the thyrotropin receptor-blocking antibodies. Both children were clinically healthy newborns without evidence of congenital malformations. Thyroid suppression, reflected by high levels of TSH during neonatal screening, was transient in both infants. Hormonal substitution was only necessary in one child for a period of 4 months. When tested at the age of 6-7 months, maternal antibodies had completely disappeared from the infants' sera. At ages 7 and 4 years respectively the 2 children do not require treatment and show normal growth and neurodevelopmental skills. In the north-eastern part of Switzerland congenital hypothyroidism has an incidence of one in 3300 live-born infants, the most frequent form being permanent congenital hypothyroidism (1:4500). In this population, analyzed over a period of 16 years, the two cases reported represent the only observations of transient neonatal hypothyroidism due to thyrotropin receptor-blocking antibodies; the incidence can thus be estimated to be approximately 1:310,000 live newborns. In this rare condition, early recognition is pertinent in order to avoid unnecessary treatment and parental anxiety.

摘要

由促甲状腺素受体阻断抗体经胎盘转移引起的暂时性新生儿甲状腺功能减退症较为罕见,但应尽早诊断,因为其病程、治疗和预后与其他形式的先天性甲状腺功能减退症不同。有母亲自身免疫性甲状腺疾病病史的婴儿应怀疑患有暂时性新生儿甲状腺功能减退症。我们描述了两名兄弟姐妹,他们的母亲自青春期起就因特发性原发性非甲状腺肿性甲状腺功能减退症接受治疗。在第一个孩子出生时,首次在母亲血清中检测到高水平的促甲状腺素受体阻断抗体。在第二个孩子出生时,除了促甲状腺素受体阻断抗体外,还发现了抗甲状腺过氧化物酶抗体。两个孩子都是临床健康的新生儿,没有先天性畸形的迹象。新生儿筛查期间促甲状腺激素水平升高所反映的甲状腺抑制在两个婴儿中都是暂时的。只有一个孩子在4个月的时间里需要激素替代治疗。在6 - 7个月大时进行检测时,母亲的抗体已从婴儿血清中完全消失。两个孩子分别在7岁和4岁时不需要治疗,生长和神经发育技能正常。在瑞士东北部,先天性甲状腺功能减退症在活产婴儿中的发病率为1/3300,最常见的形式是永久性先天性甲状腺功能减退症(1/4500)。在这一为期16年的人群分析中,报告的这两例病例是促甲状腺素受体阻断抗体导致的暂时性新生儿甲状腺功能减退症的仅有的观察病例;因此,发病率估计约为1/310,000活产新生儿。在这种罕见的情况下,早期识别很重要,以避免不必要的治疗和家长的焦虑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验